Related Experiment Video
Updated: Jun 16, 2026
04:04
Lateral Molar Approach-Driven Transoral Endoscopic Procedure for Benign Infratemporal Fossa Tumor Resection
Published on: August 15, 2025
Modern multimodality therapy for pediatric nonorbital parameningeal sarcomas.
Jose P Zevallos1, Kunal Jain, Dianna Roberts
1Department of Head and Neck Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Head & Neck
|February 23, 2010
Summary
Pediatric nonorbital parameningeal sarcomas need aggressive treatment. Surgery can be a valuable salvage option when chemotherapy and radiation are insufficient.
Area of Science:
- Pediatric Oncology
- Surgical Oncology
- Radiation Oncology
Background:
- Nonorbital parameningeal sarcomas are rare, aggressive tumors primarily affecting children.
- Understanding their management is crucial for improving outcomes.
Purpose of the Study:
- To review the management of pediatric nonorbital parameningeal sarcomas.
- To clarify the role of surgical intervention in their treatment.
Main Methods:
- Retrospective review of patient data over a 10-year period.
- Analysis of treatment modalities, prognostic factors, and patient outcomes.
Main Results:
- 34 pediatric patients were identified; 73% had rhabdomyosarcoma, most commonly in the maxillary sinus.
- 18% had nodal metastases, 10% had distant metastases. The 5-year overall survival was 66.8%.
- Locoregional recurrence was 43%, with no distant recurrences observed. Surgery was used in 18 patients.
Conclusions:
- Pediatric nonorbital parameningeal sarcomas necessitate aggressive multimodality treatment.
- Chemotherapy and radiation are standard, but surgery plays a role in salvage and refractory cases.
